| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21K | — | +11.3% |
| Cost of Revenue | $17K | — | -25.9% |
| Gross Profit | $4K | — | +183.6% |
| R&D Expense | $315K | — | +59.1% |
| SG&A Expense | $1.8M | — | +79.0% |
| Operating Income | -$3.0M | — | -100.2% |
| Pre-tax Income | -$2.9M | — | -40.1% |
| Income Tax | $0 | — | — |
| Net Income | -$2.9M | — | -40.1% |
| EPS (Basic) | -$1.34 | — | +85.6% |
| EPS (Diluted) | -$1.34 | — | +85.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.0M | +58.2% | +28.8% |
| Accounts Receivable | $41K | +36.7% | +111.7% |
| Current Assets | $19.4M | +56.3% | +27.8% |
| Total Assets | $20.6M | +51.0% | +25.2% |
| Current Liabilities | $986K | +17.8% | +41.1% |
| Total Liabilities | $986K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | -5.2% |
| Investing Cash Flow | -$49K | — | +37.0% |
| Financing Cash Flow | $9.7M | — | -42.7% |
| +41.1% |
| Stockholders' Equity | $19.7M | +53.1% | +24.5% |